{"id":"https://openalex.org/W4288069758","doi":"https://doi.org/10.2147/ott.s372134","title":"Identification of a Rare BAIAP2-ROS1 Fusion and Clinical Benefit of Crizotinib in the Treatment of Advanced Lung Adenocarcinoma: A Case Report","display_name":"Identification of a Rare BAIAP2-ROS1 Fusion and Clinical Benefit of Crizotinib in the Treatment of Advanced Lung Adenocarcinoma: A Case Report","publication_year":2022,"publication_date":"2022-07-01","ids":{"openalex":"https://openalex.org/W4288069758","doi":"https://doi.org/10.2147/ott.s372134","pmid":"https://pubmed.ncbi.nlm.nih.gov/35923471","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/9342878"},"language":"en","primary_location":{"id":"doi:10.2147/ott.s372134","doi":"https://doi.org/10.2147/ott.s372134","is_oa":true,"landing_page_url":"https://doi.org/10.2147/ott.s372134","pdf_url":"https://www.dovepress.com/getfile.php?fileID=82457","source":{"id":"https://openalex.org/S120324992","display_name":"OncoTargets and Therapy","issn_l":"1178-6930","issn":["1178-6930"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"OncoTargets and Therapy","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.dovepress.com/getfile.php?fileID=82457","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5067391086","display_name":"YunYu Lin","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"YunYu Lin","raw_affiliation_strings":["Respiratory Medicine, NingHai First Hospital, NingBo, 315600, People's Republic of China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Respiratory Medicine, NingHai First Hospital, NingBo, 315600, People's Republic of China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103252542","display_name":"Yan Lei","orcid":"https://orcid.org/0000-0002-1897-1687","observed_orcids":["https://orcid.org/0000-0002-1897-1687"]},"institutions":[{"id":"https://openalex.org/I4210141220","display_name":"Berry Oncology (China)","ror":"https://ror.org/03ey0nh96","country_code":"CN","type":"company","lineage":["https://openalex.org/I4210141220"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yan Lei","raw_affiliation_strings":["Berry Oncology Institutes, Berry Oncology Corporation, Fuzhou, 350200, People's Republic of China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Berry Oncology Institutes, Berry Oncology Corporation, Fuzhou, 350200, People's Republic of China","institution_ids":["https://openalex.org/I4210141220"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100721239","display_name":"Linwei Li","orcid":"https://orcid.org/0000-0002-8406-8322","observed_orcids":["https://orcid.org/0000-0002-8406-8322"]},"institutions":[{"id":"https://openalex.org/I4210141220","display_name":"Berry Oncology (China)","ror":"https://ror.org/03ey0nh96","country_code":"CN","type":"company","lineage":["https://openalex.org/I4210141220"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"LinWei Li","raw_affiliation_strings":["Berry Oncology Institutes, Berry Oncology Corporation, Fuzhou, 350200, People's Republic of China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Berry Oncology Institutes, Berry Oncology Corporation, Fuzhou, 350200, People's Republic of China","institution_ids":["https://openalex.org/I4210141220"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050138006","display_name":"Xiaoxing Su","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210141220","display_name":"Berry Oncology (China)","ror":"https://ror.org/03ey0nh96","country_code":"CN","type":"company","lineage":["https://openalex.org/I4210141220"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Xiaoxing Su","raw_affiliation_strings":["Berry Oncology Institutes, Berry Oncology Corporation, Fuzhou, 350200, People's Republic of China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Berry Oncology Institutes, Berry Oncology Corporation, Fuzhou, 350200, People's Republic of China","institution_ids":["https://openalex.org/I4210141220"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046237702","display_name":"Qiqi Tian","orcid":"https://orcid.org/0000-0002-4178-1785","observed_orcids":["https://orcid.org/0000-0002-4178-1785"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Qiqi Tian","raw_affiliation_strings":["Respiratory Medicine, NingHai First Hospital, NingBo, 315600, People's Republic of China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Respiratory Medicine, NingHai First Hospital, NingBo, 315600, People's Republic of China","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5109568711","display_name":"Wendy Yi-Ying Wu","orcid":"https://orcid.org/0000-0001-6048-405X","observed_orcids":["https://orcid.org/0000-0001-6048-405X"]},"institutions":[{"id":"https://openalex.org/I4210141220","display_name":"Berry Oncology (China)","ror":"https://ror.org/03ey0nh96","country_code":"CN","type":"company","lineage":["https://openalex.org/I4210141220"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Wendy Wu","raw_affiliation_strings":["Berry Oncology Institutes, Berry Oncology Corporation, Fuzhou, 350200, People's Republic of China"],"raw_orcid":"https://orcid.org/0000-0001-6048-405X","affiliations":[{"raw_affiliation_string":"Berry Oncology Institutes, Berry Oncology Corporation, Fuzhou, 350200, People's Republic of China","institution_ids":["https://openalex.org/I4210141220"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5046237702"],"corresponding_institution_ids":[],"apc_list":{"value":2836,"currency":"USD","value_usd":2836},"apc_paid":{"value":2836,"currency":"USD","value_usd":2836},"fwci":0.1596,"has_fulltext":true,"cited_by_count":1,"citation_normalized_percentile":{"value":0.39702406,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":93},"biblio":{"volume":"Volume 15","issue":null,"first_page":"831","last_page":"836"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11287","display_name":"Cancer Genomics and Diagnostics","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12334","display_name":"Lung Cancer Research Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ros1-rearrangement","display_name":"ROS1 rearrangement","score":0.9810000061988831},{"id":"https://openalex.org/keywords/lung-adenocarcinoma","display_name":"lung adenocarcinoma","score":0.9729999899864197},{"id":"https://openalex.org/keywords/crizotinib","display_name":"crizotinib","score":0.8949999809265137},{"id":"https://openalex.org/keywords/targeted-therapy","display_name":"targeted therapy","score":0.6610000133514404},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.7820000052452087},{"id":"https://openalex.org/keywords/fusion-partners","display_name":"fusion partners","score":0.5529999732971191},{"id":"https://openalex.org/keywords/protein-kinase-domain","display_name":"kinase domain","score":0.49000000953674316},{"id":"https://openalex.org/keywords/personalized-treatment","display_name":"personalized treatment","score":0.5740000009536743}],"concepts":[{"id":"https://openalex.org/C2779422266","wikidata":"https://www.wikidata.org/wiki/Q5186964","display_name":"Crizotinib","level":4,"score":0.9848159551620483},{"id":"https://openalex.org/C2775999482","wikidata":"https://www.wikidata.org/wiki/Q18031208","display_name":"ROS1","level":4,"score":0.7838742733001709},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6963682174682617},{"id":"https://openalex.org/C2781182431","wikidata":"https://www.wikidata.org/wiki/Q356033","display_name":"Adenocarcinoma","level":3,"score":0.6680141091346741},{"id":"https://openalex.org/C116834253","wikidata":"https://www.wikidata.org/wiki/Q2039217","display_name":"Identification (biology)","level":2,"score":0.6538583040237427},{"id":"https://openalex.org/C2777714996","wikidata":"https://www.wikidata.org/wiki/Q7886","display_name":"Lung","level":2,"score":0.4860151410102844},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.38163450360298157},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.36740970611572266},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.34541958570480347},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.32168036699295044},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.16527369618415833},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.1096019446849823},{"id":"https://openalex.org/C2776232967","wikidata":"https://www.wikidata.org/wiki/Q6743514","display_name":"Malignant pleural effusion","level":3,"score":0.0},{"id":"https://openalex.org/C59822182","wikidata":"https://www.wikidata.org/wiki/Q441","display_name":"Botany","level":1,"score":0.0}],"mesh":[],"locations_count":5,"locations":[{"id":"doi:10.2147/ott.s372134","doi":"https://doi.org/10.2147/ott.s372134","is_oa":true,"landing_page_url":"https://doi.org/10.2147/ott.s372134","pdf_url":"https://www.dovepress.com/getfile.php?fileID=82457","source":{"id":"https://openalex.org/S120324992","display_name":"OncoTargets and Therapy","issn_l":"1178-6930","issn":["1178-6930"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"OncoTargets and Therapy","raw_type":"journal-article"},{"id":"pmid:35923471","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/35923471","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"OncoTargets and therapy","raw_type":"Case Reports"},{"id":"pmh:oai:pubmedcentral.nih.gov:9342878","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC9342878/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Onco Targets Ther","raw_type":"Text"},{"id":"pmh:oai:doaj.org/article:55c5e8253a9e4a1abb62d339f449de16","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/55c5e8253a9e4a1abb62d339f449de16","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"OncoTargets and Therapy, Vol Volume 15, Pp 831-836 (2022)","raw_type":"article"},{"id":"pmh:oai:dovepress.com/76863","doi":null,"is_oa":true,"landing_page_url":"https://www.dovepress.com/identification-of-a-rare-baiap2-ros1-fusion-and-clinical-benefit-of-cr-peer-reviewed-fulltext-article-OTT","pdf_url":null,"source":{"id":"https://openalex.org/S4306401012","display_name":"Dove Medical Press (Taylor and Francis Group)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.2147/ott.s372134","doi":"https://doi.org/10.2147/ott.s372134","is_oa":true,"landing_page_url":"https://doi.org/10.2147/ott.s372134","pdf_url":"https://www.dovepress.com/getfile.php?fileID=82457","source":{"id":"https://openalex.org/S120324992","display_name":"OncoTargets and Therapy","issn_l":"1178-6930","issn":["1178-6930"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"OncoTargets and Therapy","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/case-report","display_name":"Case Report"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4288069758.pdf","grobid_xml":"https://content.openalex.org/works/W4288069758.grobid-xml"},"referenced_works_count":14,"referenced_works":["https://openalex.org/W1990626198","https://openalex.org/W1999130958","https://openalex.org/W2748209653","https://openalex.org/W2794491531","https://openalex.org/W3007475361","https://openalex.org/W3031489109","https://openalex.org/W3047057449","https://openalex.org/W3092373543","https://openalex.org/W3096306511","https://openalex.org/W3107681338","https://openalex.org/W3111041186","https://openalex.org/W3135689332","https://openalex.org/W4200477716","https://openalex.org/W4214621891"],"related_works":["https://openalex.org/W3092373543","https://openalex.org/W2982182224","https://openalex.org/W2964989113","https://openalex.org/W2903655979","https://openalex.org/W3210231340","https://openalex.org/W3184270659","https://openalex.org/W3201550227","https://openalex.org/W4366597751","https://openalex.org/W3135040431","https://openalex.org/W3112984161"],"abstract_inverted_index":{"Objective:":[0],"Previous":[1],"studies":[2],"have":[3,8],"shown":[4],"that":[5],"fusion":[6,19,70,105,147,183,204],"partners":[7],"a":[9,102,107,173],"potential":[10,24],"role":[11],"in":[12,41,106,121,128,145,184,202,206],"influencing":[13],"different":[14],"tumorigenic":[15],"abilities":[16],"of":[17,38,119,123,130,181,197],"ROS1":[18,39,127,146,182],"variants,":[20],"as":[21,23],"well":[22],"differential":[25],"responses":[26],"to":[27,33,60,65,79,191,216],"crizotinib.":[28],"Therefore,":[29],"it":[30,177],"is":[31],"important":[32],"accurately":[34],"identify":[35],"the":[36,195],"type":[37],"rearrangement":[40],"NSCLC":[42],"for":[43],"clinical":[44,185,207],"treatment":[45],"selection.":[46],"Materials":[47],"and":[48,126,155,199],"Methods:":[49],"Deep-coverage":[50],"targeting":[51],"solid":[52],"tumor":[53,158],"31":[54],"cancer-related":[55],"genes":[56],"panel":[57,71],"was":[58,77,148],"used":[59],"capture":[61,75],"DNA-based":[62,198],"NGS":[63,98,139,201],"information":[64],"detect":[66],"gene":[67,81],"fusion.":[68],"RNA":[69,85],"based":[72],"on":[73],"hybrid":[74],"sequencing":[76,219],"performed":[78],"verify":[80],"fusions":[82],"from":[83,88,166],"total":[84],"which":[86,133],"isolated":[87],"formalin":[89],"fixed":[90],"paraffin-embedded":[91],"(FFPE)":[92],"tissue":[93],"blocks.":[94],"Results:":[95],"Using":[96],"DNA-targeted":[97],"method,":[99],"we":[100],"identified":[101],"novel":[103,174],"BAIAP2-ROS1":[104,175,210],"71-year-old":[108],"non-smoking":[109],"female":[110],"patient":[111,151],"with":[112],"stage":[113],"IVB":[114],"lung":[115,213],"adenocarcinoma.":[116],"Rearrangement":[117],"consisted":[118],"BAIAP2":[120],"exon1-exon13":[122],"chr17:":[124],"q23":[125],"exon35-exon43":[129],"chr6:":[131],"q22,":[132],"were":[134],"further":[135],"confirmed":[136],"by":[137],"RNA-based":[138,200],"methodology.":[140],"A":[141],"complete":[142],"kinase":[143],"domain":[144],"preserved.":[149],"The":[150,188],"subsequently":[152],"received":[153],"crizotinib":[154,192],"showed":[156],"significant":[157],"reduction":[159],"until":[160],"17":[161],"months,":[162],"who":[163],"got":[164],"benefit":[165],"targeted":[167],"therapy.":[168],"Conclusion:":[169],"This":[170],"study":[171],"discovered":[172],"rearrangement;":[176],"provides":[178],"more":[179],"knowledge":[180],"personalized":[186],"treatment.":[187],"good":[189],"response":[190],"therapy":[193],"emphasizes":[194],"importance":[196],"rare":[203],"identification":[205],"practice.":[208],"Keywords:":[209],"fusion,":[211],"advanced":[212],"adenocarcinoma,":[214],"sensitive":[215],"crizotinib,":[217],"next-generation":[218]},"counts_by_year":[{"year":2025,"cited_by_count":1}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2022-07-28T00:00:00"}